Phase II Study of Docetaxel in Combination with Everolimus for Second- or Third-Line Therapy of Advanced Non–Small-Cell Lung CancerSuresh S. Ramalingam, Fadlo R. Khuri, Madhusmita Behera et al.|Journal of Thoracic Oncology|2013Cited by 39